HBM Healthcare Investments

SW:HBMN Switzerland Asset Management
Market Cap
$1.54 Billion
CHF1.41 Billion CHF
Market Cap Rank
#34091 Global
#124 in Switzerland
Share Price
CHF214.50
Change (1 day)
+1.18%
52-Week Range
CHF159.60 - CHF244.50
All Time High
CHF323.96
Categories
Companies in Switzerland Asset Management Banking & Financial
About

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds… Read more

HBM Healthcare Investments (HBMN) - Net Assets

Latest net assets as of December 2025: CHF1.86 Billion CHF

Based on the latest financial reports, HBM Healthcare Investments (HBMN) has net assets worth CHF1.86 Billion CHF as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF2.04 Billion) and total liabilities (CHF177.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF1.86 Billion
% of Total Assets 91.32%
Annual Growth Rate 3.48%
5-Year Change -23.52%
10-Year Change 61.33%
Growth Volatility 18.82

HBM Healthcare Investments - Net Assets Trend (2002–2025)

This chart illustrates how HBM Healthcare Investments's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for HBM Healthcare Investments (2002–2025)

The table below shows the annual net assets of HBM Healthcare Investments from 2002 to 2025.

Year Net Assets Change
2025-03-31 CHF1.65 Billion -3.43%
2024-03-31 CHF1.70 Billion -3.88%
2023-03-31 CHF1.77 Billion -10.76%
2022-03-31 CHF1.99 Billion -7.67%
2021-03-31 CHF2.15 Billion +48.50%
2020-03-31 CHF1.45 Billion +9.90%
2019-03-31 CHF1.32 Billion +13.85%
2018-03-31 CHF1.16 Billion +5.67%
2017-03-31 CHF1.10 Billion +7.43%
2016-03-31 CHF1.02 Billion -5.05%
2015-03-31 CHF1.07 Billion +16.72%
2014-03-31 CHF920.34 Million +53.14%
2013-03-31 CHF600.96 Million +9.99%
2012-03-31 CHF546.39 Million -7.27%
2011-03-31 CHF589.23 Million -11.55%
2010-03-31 CHF666.15 Million +7.63%
2009-03-31 CHF618.93 Million -34.73%
2008-03-31 CHF948.33 Million -20.91%
2007-03-31 CHF1.20 Billion +14.40%
2006-03-31 CHF1.05 Billion +19.46%
2005-03-31 CHF877.35 Million +1.56%
2004-03-31 CHF863.89 Million +8.02%
2003-03-31 CHF799.78 Million +6.83%
2002-03-31 CHF748.62 Million --

Equity Component Analysis

This analysis shows how different components contribute to HBM Healthcare Investments's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 12214.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Retained Earnings CHF1.51 Billion 91.89%
Common Stock CHF32.02 Million 1.95%
Other Comprehensive Income CHF143.25 Million 8.71%
Total Equity CHF1.65 Billion 100.00%

HBM Healthcare Investments Competitors by Market Cap

The table below lists competitors of HBM Healthcare Investments ranked by their market capitalization.

Company Market Cap
Viji Finance Limited
NSE:VIJIFIN
 		$2.12 Million
MAS Gold Corp
PINK:MSGCF
 		$2.12 Million
Orgabio Holdings Bhd
KLSE:0252
 		$2.12 Million
Reliability Incorporated
PINK:RLBY
 		$2.12 Million
America Great Health
PINK:AAGH
 		$2.12 Million
Albion Resources Ltd
AU:ALB
 		$2.11 Million
Exent Corp
PINK:EXNN
 		$2.11 Million
Indo Pureco Pratama Tbk PT
JK:IPPE
 		$2.11 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in HBM Healthcare Investments's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,703,865,000 to 1,645,431,000, a change of -58,434,000 (-3.4%).
  • Net income of 18,542,000 contributed positively to equity growth.
  • Dividend payments of 51,202,000 reduced retained earnings.
  • Share repurchases of 77,293,000 reduced equity.
  • Other comprehensive income increased equity by 997,999.
  • Other factors increased equity by 50,521,001.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CHF18.54 Million +1.13%
Dividends Paid CHF51.20 Million -3.11%
Share Repurchases CHF77.29 Million -4.7%
Other Comprehensive Income CHF998.00K +0.06%
Other Changes CHF50.52 Million +3.07%
Total Change CHF- -3.43%

Book Value vs Market Value Analysis

This analysis compares HBM Healthcare Investments's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.89x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 1.26x to 0.89x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-03-31 CHF170.72 CHF214.50 x
2003-03-31 CHF99.01 CHF214.50 x
2004-03-31 CHF83.21 CHF214.50 x
2005-03-31 CHF82.57 CHF214.50 x
2006-03-31 CHF93.06 CHF214.50 x
2007-03-31 CHF106.45 CHF214.50 x
2008-03-31 CHF84.88 CHF214.50 x
2009-03-31 CHF57.33 CHF214.50 x
2010-03-31 CHF64.42 CHF214.50 x
2011-03-31 CHF59.86 CHF214.50 x
2012-03-31 CHF57.94 CHF214.50 x
2013-03-31 CHF67.42 CHF214.50 x
2014-03-31 CHF106.68 CHF214.50 x
2015-03-31 CHF135.46 CHF214.50 x
2016-03-31 CHF133.27 CHF214.50 x
2017-03-31 CHF151.94 CHF214.50 x
2018-03-31 CHF165.39 CHF214.50 x
2019-03-31 CHF189.49 CHF214.50 x
2020-03-31 CHF208.25 CHF214.50 x
2021-03-31 CHF309.25 CHF214.50 x
2022-03-31 CHF285.54 CHF214.50 x
2023-03-31 CHF254.81 CHF214.50 x
2024-03-31 CHF245.80 CHF214.50 x
2025-03-31 CHF241.80 CHF214.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently HBM Healthcare Investments utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.13%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 82.88%
  • • Asset Turnover: 0.01x
  • • Equity Multiplier: 1.06x
  • Recent ROE (1.13%) is below the historical average (3.77%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 -1.64% -49.39% 0.03x 1.00x CHF-87.14 Million
2003 -19.52% -357.42% 0.05x 1.01x CHF-236.12 Million
2004 7.42% 37.54% 0.20x 1.01x CHF-22.28 Million
2005 6.56% 55.66% 0.12x 1.01x CHF-30.20 Million
2006 13.82% 106.16% 0.13x 1.01x CHF40.02 Million
2007 12.59% 76.99% 0.14x 1.17x CHF31.00 Million
2008 -23.44% -104.12% 0.19x 1.20x CHF-317.14 Million
2009 -50.55% -283.80% 0.14x 1.31x CHF-374.77 Million
2010 9.91% 73.33% 0.11x 1.18x CHF-581.80K
2011 -9.57% 0.00% -0.06x 1.07x CHF-115.30 Million
2012 -4.06% 0.00% -0.03x 1.00x CHF-76.81 Million
2013 11.15% 85.80% 0.13x 1.00x CHF6.91 Million
2014 38.41% 99.09% 0.39x 1.01x CHF261.49 Million
2015 23.97% 98.70% 0.22x 1.11x CHF150.09 Million
2016 2.33% 87.43% 0.02x 1.10x CHF-78.19 Million
2017 12.48% 96.04% 0.12x 1.09x CHF27.20 Million
2018 10.01% 95.69% 0.10x 1.09x CHF84.40K
2019 13.86% 85.75% 0.15x 1.08x CHF50.87 Million
2020 12.61% 98.13% 0.12x 1.07x CHF37.82 Million
2021 35.15% 98.69% 0.34x 1.05x CHF541.12 Million
2022 -3.93% 0.00% -0.04x 1.08x CHF-276.68 Million
2023 -8.25% 0.00% -0.07x 1.09x CHF-323.59 Million
2024 -0.06% -35.21% 0.00x 1.06x CHF-171.47 Million
2025 1.13% 82.88% 0.01x 1.06x CHF-146.00 Million

Industry Comparison

This section compares HBM Healthcare Investments's net assets metrics with peer companies in the Asset Management industry.

Industry Context

  • Industry: Asset Management
  • Average net assets among peers: $972,157,081
  • Average return on equity (ROE) among peers: 14.02%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
HBM Healthcare Investments (HBMN) CHF1.86 Billion -1.64% 0.10x $2.12 Million
Alpine Select AG (ALPN) $67.68 Million 1.80% 0.02x $15.20 Million
Julius Baer Gruppe AG (BAER) $4.31 Billion 5.99% 11.28x $13.26 Billion
Bellevue Group AG (BBN) $133.89 Million 18.90% 0.38x $85.72 Million
Nebag ag (NBEN) $82.49 Million 6.78% 0.01x $49.55 Million
Private Equity Holding AG (PEHN) $210.59 Million 9.57% 0.01x $613.71K
Partners Group Holding AG (PGHN) $1.54 Billion 36.22% 0.25x $19.65 Billion
VZ Holding AG (VZN) $459.47 Million 18.88% 4.88x $2.45 Billion